Yasaman Emad
Overview
Explore the profile of Yasaman Emad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Emad Y, Neef S, Taylor L, Kerse N, Cavadino A, Moyes S, et al.
J Appl Gerontol
. 2024 Dec;
:7334648241302552.
PMID: 39626350
To compare lighting levels in care facilities with local recommendations and determine their cross-sectional association with fall rate, we recruited residents ( = 126) from 12 long-term care facilities (mean...
2.
Emad Y, Derksen C, Petrie K, Dalbeth N
Rheumatol Adv Pract
. 2024 Apr;
8(2):rkae042.
PMID: 38629107
Objective: This study aimed to investigate how medication adherence is addressed in online gout resources in six countries. We investigated how often adherence was referred to, the strategies suggested to...
3.
Emad Y, Dalbeth N, Weinman J, Chalder T, Petrie K
J Rheumatol
. 2023 Nov;
51(2):189-196.
PMID: 37967906
Objective: This feasibility study aimed to assess the acceptability of using smartphone notifications to modify the medication beliefs of people with gout. We evaluated the feasibility and acceptability of a...
4.
Emad Y, Dalbeth N, Weinman J, Chalder T, Petrie K
J Rheumatol
. 2022 Feb;
49(6):622-626.
PMID: 35169055
Objective: The objectives of this study were to examine the reasons patients give for nonadherence to allopurinol and to examine differences in intentional nonadherence for patients who did and did...
5.
MacKrill K, Webster R, James Rubin G, Witthoft M, Silvester C, Emad Y, et al.
J Psychosom Res
. 2020 Dec;
141:110340.
PMID: 33352479
Objectives: Symptom misattribution is a central process in the nocebo effect but it is not accurately assessed in current side effect measures. We have developed a new measure, the Side...
6.
Emad A, Emad Y
J Aerosol Med
. 2007 Sep;
20(3):352-60.
PMID: 17894541
The objective of this article was to show the role of cytokines in the pathogenesis of pulmonary fibrosis due to sulfur mustard gas inhalation. Eighteen veterans with mustard gas-induced pulmonary...
7.
Emad A, Emad Y
J Aerosol Med
. 2007 Sep;
20(3):342-51.
PMID: 17894540
The objective of this article was to evaluate the relationship between the bronchial reactivity to methacholine and distilled cold water and inflammatory bronchial alveolar lavage (BAL) cells in mustard gas-induced...
8.
Emad A, Emad Y
J Clin Immunol
. 2007 Jul;
27(6):605-12.
PMID: 17620002
Objective: Therefore, this study was designed to analyze the bronchoalveolar lavage (BAL) fluid concentrations of IL-5, RANTES (CCL5) and eotaxin (CCL11) and also to examine the relationship between the percentage...
9.
Emad A, Emad Y
J Clin Immunol
. 2007 Jun;
28(4):298-305.
PMID: 17597386
Objective: Therefore, this study was designed to analyze the bronchoalveolar lavage (BAL) fluid concentrations of interleukin-5 (IL-5), normal T cell expressed and presumably secreted (RANTES; CCL5), and eotaxin (CCL11) and...
10.
Emad A, Emad Y
Clin Toxicol (Phila)
. 2007 Jun;
45(5):565-70.
PMID: 17558630
Objective: To evaluate bronchial challenges using three different stimuli as screening tools for bronchial hyper-responsiveness in sulfur mustard gas-induced asthma. Design: Randomized, cross-over clinical study. Setting: University hospital. Patients: Eighteen...